Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds'
7th August 2025 Uncategorised 0As the Trump administration seeks to align U.S. drug prices with lower reference costs in places like Europe, Eli Lilly’s CEO has cautioned that flaws in the American healthcare system, which “isn’t built to function for patients,” could complicate an otherwise commendable goal.
More: Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds'
Source: fierce
